Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
PTH
48
HOLDINGS
31%
ALSO IN SBIO
SBIO
92
HOLDINGS
13%
ALSO IN PTH
SECTOR DRIFT (PTH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PTH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
RHYTHM PHARMACEUTICALS, INC. | 2.4% | 3.6% | 2.4% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.0% | 2.2% | 2.2% |
|
AKERO THERAPEUTICS, INC. | 2.4% | 2.0% | 2.0% |
 |
MERUS N.V. | 1.8% | 2.7% | 1.8% |
|
MIRUM PHARMACEUTICALS, INC. | 1.7% | 1.9% | 1.7% |
PTH Overweight Relative to SBIO
|
INSMED INC | 6.7% |
|
UNIQURE N.V. | 5.4% |
|
TENET HEALTHCARE CORP | 5.1% |
|
HIMS & HERS HEALTH, INC. CLASS A | 5.1% |
|
BOSTON SCIENTIFIC CORP | 4.5% |
|
CENCORA INC | 3.5% |
|
PHATHOM PHARMACEUTICALS, INC. | 3.3% |
|
RADNET INC | 3.2% |
|
EXELIXIS INC | 3.0% |
|
INSULET CORP | 3.0% |
PTH Underweight Relative to SBIO
|
AVIDITY BIOSCIENCES INC | -3.3% |
|
CYTOKINETICS INC | -3.1% |
|
AXSOME THERAPEUTICS, INC. | -3.1% |
|
NUVALENT, INC. CLASS A | -2.8% |
|
KRYSTAL BIOTECH, INC. | -2.5% |
|
CRINETICS PHARMACEUTICALS INC | -2.4% |
 |
ALKERMES PLC | -2.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.4% |
|
VAXCYTE, INC. | -2.3% |
|
ARCELLX, INC. | -2.2% |